Sigilon Therapeutics, Inc. Contracts & Agreements

56 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Sigilon Therapeutics, Inc. 2016 Equity Incentive Plan (as Amended)
Equity Distribution Agreements
Sigilon Therapeutics, Inc.
Biotechnology
DE
2023
Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan (as amended May 23, 2023)
Equity Distribution Agreements
Sigilon Therapeutics, Inc.
Biotechnology
DE
2023
Sigilon Therapeutics, Inc. 2020 Employee Stock Purchase Plan (as amended May 23, 2023)
Stock Agreements
Sigilon Therapeutics, Inc.
Biotechnology
DE
2023
Sigilon Therapeutics, Inc. Non-Employee Director Compensation Policy (as amended May 23, 2023)
Compensation Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2023
Consulting Agreement between Sigilon Therapeutics, Inc. and Rare Disease and Oncology Consulting, LLC/May Orfali, MD, MBA
Consulting Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2023
Separation and Consulting Agreement between Sigilon Therapeutics, Inc. and May Orfali, M.D.
Separation Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2023
Sigilon Therapeutics, Inc. Executive Employment Offer Letter to Qing Sarah Yuan, Ph.D.
Employment Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2023
Sigilon, Inc. Employment Offer Letter to Josias Fantato de Pontes as VP, Head of Finance
Employment Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2023
Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan Restricted Stock Unit Agreement with Participant
Equity Distribution Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2023
First Amendment to Research Collaboration and Exclusive License Agreement between Sigilon Therapeutics, Inc. and Eli Lilly and Company
License Agreements
Sigilon Therapeutics, Inc.
Biotechnology
NY
2022
Sixth Amendment to Exclusive Patent License Agreement between MIT and Sigilon Therapeutics, Inc.
License Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2022
Sigilon Therapeutics, Inc. Executive Employment Offer Letter to May Orfali, MD, MBA
Employment Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2022
Sigilon Therapeutics, Inc. Offer Letter to Philip Ashton-Rickardt for Chief Scientific Officer Position
Employment Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2022
Sigilon Therapeutics, Inc. Chief Medical Officer Employment Agreement with Deya Corzo, MD (2018)
Employment Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2022
Sigilon Therapeutics, Inc. and Deya Corzo, M.D. Transition and Separation Agreement (August 2021)
Separation Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2022
Consulting Agreement between Sigilon Therapeutics, Inc. and Rare Disease and Oncology Consulting, LLC (May Orfali, MD, MBA)
Consulting Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2022
Fifth Amendment to Exclusive Patent License Agreement between MIT and Sigilon Therapeutics, Inc.
License Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2021
Consulting Agreement between Sigilon Therapeutics, Inc. and Devn Smith, Ph.D. dated April 26, 2021
Consulting Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2021
Description of Common and Preferred Stock of Sigilon Therapeutics, Inc.
Stock Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2021
Second Amendment to Lease Agreement between ARE-MA Region No. 45, LLC and Sigilon Therapeutics, Inc.
Lease Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2021
Fourth Amendment to Exclusive Patent License Agreement between MIT and Sigilon Therapeutics, Inc.
License Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2021
Underwriting Agreement between Sigilon Therapeutics, Inc. and Morgan Stanley & Co. LLC and Jefferies LLC (2020)
Underwriting Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2020
Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan
Equity Distribution Agreements
Sigilon Therapeutics, Inc.
Biotechnology
DE
2020
Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan Non-Statutory Stock Option Agreement (Non-Employee Directors)
Warrant Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan Non-Statutory Stock Option Agreement with Participant
Warrant Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan Incentive Stock Option Agreement with Participant
Warrant Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Sigilon Therapeutics, Inc. 2020 Employee Stock Purchase Plan
Bonus & Incentive Agreements
Sigilon Therapeutics, Inc.
Biotechnology
DE
2020
Third Amended and Restated Investors' Rights Agreement among Sigilon Therapeutics, Inc., Investors, and MIT
Investor Rights Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2020
Warrant to Purchase Series A-1 Preferred Stock Agreement between Sigilon Therapeutics, Inc. and Pacific Western Bank
Warrant Agreements
Sigilon Therapeutics, Inc.
Biotechnology
DE
2020
Warrant to Purchase Series B Preferred Stock between Sigilon Therapeutics, Inc. and Pacific Western Bank
Warrant Agreements
Sigilon Therapeutics, Inc.
Biotechnology
DE
2020
Warrant to Purchase Series B Preferred Stock between Sigilon Therapeutics, Inc. and Oxford Finance LLC (September 2, 2020)
Warrant Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2020
Lease Agreement between ARE-MA Region No. 45, LLC and Sigilon Therapeutics, Inc. for 100 Binney Street, Cambridge, MA
Lease Agreements
Sigilon Therapeutics, Inc.
Biotechnology
DE
2020
Lease Agreement between ARE-MA Region No. 45, LLC and Foghorn Therapeutics Inc. for 100 Binney Street, Cambridge, MA
Lease Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Assignment and Assumption of Lease Agreement between Foghorn Therapeutics Inc. and Sigilon Therapeutics, Inc.
Assignment Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2020
Consent to Assignment and First Amendment to Lease among ARE-MA Region No. 45, LLC, Foghorn Therapeutics Inc., and Sigilon Therapeutics, Inc.
Lease Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Loan and Security Agreement between Oxford Finance LLC, Lenders, and Sigilon Therapeutics, Inc. (September 2, 2020)
Loan Agreements
Sigilon Therapeutics, Inc.
Biotechnology
NY
2020
Exclusive Patent License Agreement between Massachusetts Institute of Technology and Sigilon, Inc.
License Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2020
First Amendment to Exclusive Patent License Agreement between Sigilon, Inc. and Massachusetts Institute of Technology
License Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Second Amendment to Exclusive Patent License Agreement between Massachusetts Institute of Technology and Sigilon Therapeutics, Inc.
License Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Third Amendment to Exclusive Patent License Agreement between Massachusetts Institute of Technology and Sigilon Therapeutics, Inc.
License Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Research Collaboration and Exclusive License Agreement between Sigilon Therapeutics, Inc. and Eli Lilly and Company (April 2, 2018)
License Agreements
Sigilon Therapeutics, Inc.
Biotechnology
IN
2020
Sigilon Therapeutics, Inc. 2016 Equity Incentive Plan (as Amended September 12, 2019)
Bonus & Incentive Agreements
Sigilon Therapeutics, Inc.
Biotechnology
DE
2020
Sigilon Therapeutics, Inc. Incentive Stock Option Agreement under 2016 Equity Incentive Plan
Equity Distribution Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Sigilon Therapeutics, Inc. Nonstatutory Stock Option Agreement under 2016 Equity Incentive Plan
Warrant Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Sigilon Therapeutics, Inc. Employment Agreement with Rogerio Vivaldi (President and CEO)
Employment Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Sigilon Therapeutics Offer Letter of Employment to Glenn Reicin as Chief Financial Officer
Employment Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Sigilon, Inc. Employment Offer Letter for Chief Operations Officer and Head of Strategy (Devyn Smith)
Employment Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Severance Waiver and Offer Letter Amendment between Sigilon Therapeutics, Inc. and Rogerio Vivaldi Coelho
Severance Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Severance Waiver and Letter Agreement Amendment between Sigilon Therapeutics, Inc. and Executive
Separation Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Stock Restriction Agreement between Sigilon, Inc. and Daniel G. Anderson dated February 10, 2016
Stock Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2020
Stock Restriction Agreement between Sigilon, Inc. and Robert S. Langer Dated February 5, 2016
Stock Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2020
Sigilon Therapeutics Inc. Amended and Restated Severance and Change in Control Policy (2020)
Severance Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Sigilon Therapeutics, Inc. 2020 Cash Incentive Plan
Bonus & Incentive Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2020
Sigilon Therapeutics, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Agreement and Plan of Merger among Eli Lilly and Company, Shenandoah Acquisition Corporation, and Sigilon Therapeutics, Inc. (June 28, 2023)
Merger Agreements
Sigilon Therapeutics, Inc.
Biotechnology
NY
2023
Contingent Value Rights Agreement among Eli Lilly and Company, Shenandoah Acquisition Corporation, and Rights Agent (2023)
Sigilon Therapeutics, Inc.
Biotechnology
DE
2023